Login / Signup

A phase I dose-finding trial of hyperthermic intraperitoneal docetaxel combined with cisplatin in patients with advanced-stage ovarian cancer.

Zhi-Yao YouMiao-Fang WuHui LiYan-Fang YeLi-Juan WangZhong-Qiu LinJing Li
Published in: Journal of gynecologic oncology (2023)
ClinicalTrials.gov Identifier: NCT05410483.
Keyphrases
  • phase iii
  • study protocol
  • phase ii
  • clinical trial
  • locally advanced
  • randomized controlled trial